Search Results
Dr. Kulke on Emerging Cabozantinib Data for NETs
Yale Cancer Center Grand Rounds: Matthew Kulke, MD
Dr. Chan Discusses Cabozantinib for the Treatment of NETs
Dr. Chan on Trial of Cabozantinib in Neuroendocrine Tumors
Treatments on the Horizon in NETs
Cabozantinib demonstrates disease control in advanced adrenocortical carcinoma
New Ways to Treat NETs - Blase Polite
Cabozantinib: The METEOR Trial
Novel Neuroendocrine Tumor (NET) Therapies
Matthew Kulke, MD | FDA Approves Carcinoid Syndrome drug
Dr. Matthew H. Kulke Talks About Telotristat Etiprate Benefitting Carcinoid Syndrome Patients
CABOSUN: Upfront Use of Cabozantinib for mRCC
